The protection of telomere ends by the shelterin complex prevents DNA damage signalling and promiscuous repair at chromosome ends. Evidence suggests that the 3′ single-stranded telomere end can assemble into a lasso-like t-loop configuration 1,2 , which has been proposed to safeguard chromosome ends from being recognized as DNA double-strand breaks 2 . Mechanisms must also exist to transiently disassemble t-loops to allow accurate telomere replication and to permit telomerase access to the 3′ end to solve the end-replication problem. However, the regulation and physiological importance of t-loops in the protection of telomere ends remains unknown. Here we identify a CDK phosphorylation site in the shelterin subunit at Ser365 of TRF2, whose dephosphorylation in S phase by the PP6R3 phosphatase provides a narrow window during which the RTEL1 helicase can transiently access and unwind t-loops to facilitate telomere replication. Re-phosphorylation of TRF2 at Ser365 outside of S phase is required to release RTEL1 from telomeres, which not only protects t-loops from promiscuous unwinding and inappropriate activation of ATM, but also counteracts replication conflicts at DNA secondary structures that arise within telomeres and across the genome. Hence, a phospho-switch in TRF2 coordinates the assembly and disassembly of t-loops during the cell cycle, which protects telomeres from replication stress and an unscheduled DNA damage response.
The protection of telomere ends by the shelterin complex prevents DNA damage signalling and promiscuous repair at chromosome ends. Evidence suggests that the 3′ single-stranded telomere end can assemble into a lasso-like t-loop configuration 1, 2 , which has been proposed to safeguard chromosome ends from being recognized as DNA double-strand breaks 2 . Mechanisms must also exist to transiently disassemble t-loops to allow accurate telomere replication and to permit telomerase access to the 3′ end to solve the end-replication problem. However, the regulation and physiological importance of t-loops in the protection of telomere ends remains unknown. Here we identify a CDK phosphorylation site in the shelterin subunit at Ser365 of TRF2, whose dephosphorylation in S phase by the PP6R3 phosphatase provides a narrow window during which the RTEL1 helicase can transiently access and unwind t-loops to facilitate telomere replication. Re-phosphorylation of TRF2 at Ser365 outside of S phase is required to release RTEL1 from telomeres, which not only protects t-loops from promiscuous unwinding and inappropriate activation of ATM, but also counteracts replication conflicts at DNA secondary structures that arise within telomeres and across the genome. Hence, a phospho-switch in TRF2 coordinates the assembly and disassembly of t-loops during the cell cycle, which protects telomeres from replication stress and an unscheduled DNA damage response.
Telomere homeostasis is crucially dependent on the function of the shelterin complex but how this is regulated during the cell cycle remains uncertain. Using phospho-proteomic analysis of the shelterin complex, we identified a putative CDK2 phosphorylation site in human TRF2 at Ser365 (Ser367 in mouse; Extended Data Fig. 1a ), which is abolished by treatment with λ-protein phosphatase (Fig. 1a , left and middle) or mutation of the phospho-site to alanine (Myc-tagged TRF2(S367A); Fig. 1a, right) . Analysis of the cell cycle revealed that this modification is abundant in G1, G2 and M phases but is markedly reduced in S phase (Fig. 1b, Extended Data Fig. 1b ).
Deletion of Trf2 (also known as Terf2) results in telomere deprotection and chromosome end-to-end fusions 3 (Fig. 1c, right) . By contrast, Trf2 F/− mouse embryonic fibroblasts (MEFs) complemented with wildtype TRF2 or phospho-dead (Myc-TRF2(S367A)) or phospho-mimetic (Myc-TRF2(S367D) and Myc-TRF2(S367E)) mutants lacked telomere fusions ( Fig. 1c , left, Extended Data Fig. 1c, d) . The TRF2 Ser367 mutants also retained interactions with other shelterin proteins, including TRF1 and RAP1, and depletion of RAP1 did not result in telomere fusions in cells expressing Myc-TRF2(S367A) 4 (Extended Data Fig. 2a-c) . Hence, TRF2 Ser367 mutants retain the ability to engage with other shelterin components and to protect telomeres against fusions.
Further analysis of TRF2-null cells expressing the TRF2 Ser367 mutants showed that the phospho-dead Ser367Ala mutant (Myc-TRF2(S367A)) resulted in high levels of telomere fragility, which indicates problems in telomere replication 5 , whereas the phospho-mimetic mutants (Myc-TRF2(S367D/E)) resulted in frequent loss of telomeres, signal-free ends and high levels of extra-chromosomal telomere circles 6 ( Fig. 1d-g) . Because the distinct phenotypes of the phospho-dead and phosphomimetic TRF2 Ser367 mutants resemble cells that fail to recruit the helicase RTEL1 to replication forks and telomeres, respectively 7 , we reasoned that Ser365 or Ser367 of TRF2 might serve as a phospho-dependent TRF2-RTEL1 protein-interaction surface, which could cooperate with the TRFH domain that was previously shown to interact with RTEL1 8 . Pull-down experiments using biotinylated human TRF2 peptides encompassing amino acids 354-383 revealed a prominent RTEL1 band with the unphosphorylated peptide (S365) but not with the phosphorylated peptide (pS365) or an unrelated TRF2 control peptide (384-413) ( Fig. 2a , b, Extended Data Fig. 3a ). These results raised the possibility that the phosphorylation of Ser365 or Ser367 of TRF2 negatively regulates the interaction between TRF2 and RTEL1. The addition of λ-protein phosphatase was found to enhance this association in cell extracts ( Fig. 2c ), whereas addition of the phosphatase inhibitor PhosSTOP prevented a robust TRF2-RTEL1 interaction (Fig. 2c ). Treatment of cells with the CDK inhibitor R-roscovitine, but not with a PLK1 inhibitor (BI-2536), also enhanced levels of Myc-TRF2 co-immunoprecipitated with RTEL1 Article (Fig. 2d ). The interaction of RTEL1 with wild-type Myc-TRF2, but not with the Myc-TRF2(S365A) mutant, was inhibited after incubation with recombinant cyclinA-CDK2 ( Fig. 2e ), which supports previous findings that Ser365 of TRF2 is a cyclinA-CDK substrate 9 . Inhibition of ERK1/2 also had no effect on the phosphorylation of TRF2(Ser365) 10 (Extended Data Fig. 3b ). Whereas both phospho-mimetic mutants abolished the TRF2-RTEL1 interaction in cells, the phospho-dead Myc-TRF2(S367A) mutant interacted to a much greater extent with RTEL1 compared with wild-type Myc-TRF2 ( Fig. 2f, g) . Hence, TRF2 phospho-mimetic mutants abrogate the TRF2-RTEL1 interaction, which results in telomere loss and increased telomere circles, whereas the phospho-dead TRF2(S367A) mutant enhances the TRF2-RTEL1 interaction and results in telomere fragility. We conclude that CDK phosphorylation of TRF2 at Ser365 or Ser367 inhibits its interaction with RTEL1.
Given that phosphorylation of TRF2 at Ser365 is markedly reduced in S phase when TRF2 recruits RTEL1 to telomeres 8 , we considered the possibility that TRF2 Ser365 is actively de-phosphorylated. TRF2 and RTEL1 complexes purified from S phase and asynchronous cells contained a number of phosphatases and/or regulatory subunits that showed increased association with TRF2 and/or RTEL1 in S phase, including UBLCP1, PP1R10, PP4R1, PP4R2, PP6R2, PP2R5C and PP6R3 (Extended Data Fig. 4a ). Of these phosphatases, knockdown by short interfering RNA (siRNA) of PP4R2 or PP6R3 or their respective catalytic subunits (PP4C or PP6C, respectively), greatly reduced the TRF2-RTEL1 interaction in two different cell lines (Extended Data Figs. 4b, c, 5a, b). Co-immunoprecipitation studies confirmed that PP4R2 and PP6R3 regulatory subunits interact with TRF2 and RTEL1 in vivo (Extended Data Fig. 4d ). Notably, phosphorylation of human TRF2 at Ser365 and mouse TRF2 at Ser367 were greatly enhanced after silencing of PP6R3 but not in cells subjected to PP4R2 knockdown (Extended Data Fig. 5c,  d ). Cells depleted of the PP4R2 or PP6R3 regulatory subunits also exhibited telomere loss (Extended Data Fig. 5e ) and a greater than threefold or HEK 293 cells expressing mouse Myc-tagged TRF2 (Myc-TRF2) or the indicated mutants (right) were pre-treated with λ-protein phosphatase (λPP) and subject to western blotting. Ctrl, control; IP, immunoprecipitate; S/A, phospho-dead mutant Myc-TRF2(Ser367Ala); WT, wild type. b, IgG control and endogenous phospho-TRF2 immunoprecipitates from HEK 293 cells at the indicated stages of the cell cycle. c-f, Quantification of telomere fusions (c), telomere fragility (d, e) and telomere loss (f) per metaphase from Trf2 F/− MEFs stably expressing the indicated Trf2 genotypes (n = 35 analysed metaphases). S/D and S/E, phospho-mimetic Myc-TRF2 mutants Ser367Asp and Ser367Glu, respectively.
Data are mean ± s.e.m. Representative images of telomere FISH experiments are shown in c and e. Asterisks indicate telomere fragility, arrowheads denote loss of telomere signal. Red, telomere peptide nucleic acid (PNA) FISH; blue, DAPI. g, Phi29-dependent telomere circles (TCs; top) and quantification (bottom) in DNA isolated from Trf2 F/− MEFs stably expressing empty vector control, wild-type or mutant TRF2, 96 h after infection with control or Creexpressing adenovirus (Ad-GFP or Ad-Cre-GFP, respectively). Data are mean ± s.d. from three independent experiments. In a-f, experiments were independently repeated at least twice with similar results. All P values determined by one-way analysis of variance (ANOVA). induction in telomere circles when compared with controls (Extended Data Fig. 5f ). These data indicate that PP6R3 dephosphorylates TRF2 Ser365 or Ser367 to permit the transient recruitment of RTEL1 to telomeres in S phase. Because RTEL1 facilitates global and telomere replication through its ability to interact with PCNA 11 , we considered the possibility that the phospho-dead TRF2(S367A) mutant might sequester RTEL1 and limit its ability to bind PCNA. Indeed, cells expressing the phospho-dead TRF2(S367A) mutant, but not wild-type TRF2 or the phospho-mimetic mutants, were compromised for the RTEL1-PCNA interaction in co-immunoprecipitation and proximity ligation assay (PLA) experiments ( Fig. 2h, i ). Furthermore, analysis of global replication dynamics revealed that TRF2-null cells expressing the phospho-dead TRF2(S367A) mutant, but not wild-type TRF2 or the phospho-mimetic mutants, exhibited reduced replication fork extension rates and increased asymmetric forks across the genome (Fig. 3a , Extended Data Fig. 6a, b ). Cells expressing the Myc-TRF2(S367A) phospho-dead mutant also exhibited increased levels of replication stress, which manifested subjected to an in vitro immunoprecipitation kinase assay with ATP and purified cyclinA-CDK2 complex (CycA-CDK2), resolved by SDS-PAGE and blotted using anti-Myc (TRF2) and anti-RTEL1 antibodies. Input (5%) is shown on the right. f, h, Immunoprecipitates were resolved by SDS-PAGE and analysed by western blotting for co-precipitated Myc-TRF2 (f) or PCNA (h). Input (5%) is shown. g, i, Cells as in f and h were quantified by in situ PLA assay for the interaction between Myc-TRF2 and RTEL1 (g) or PCNA and RTEL1 (i). Data are mean ± s.e.m.; n = 50 nuclei analysed. In b-i, experiments were independently repeated at least twice with similar results. P values determined by one-way ANOVA.
Article
as micronuclei, mitotic catastrophe and increased 53BP1 nuclear foci (Extended Data Fig. 6c-f ). We reasoned that if the phospho-dead TRF2(S367A) mutant sequesters RTEL1 at telomeres, then expressing RTEL1 with a mutation in the C4C4 motif that is defective for TRF2 binding 8 (RTEL1(R1237H)) should mitigate this effect. Indeed, co-expression of the phospho-dead Flag-tagged TRF2(S367A) with the V5-tagged RTEL1(R1237H) mutant, but not with wild-type V5-RTEL1, restored the interaction between RTEL1 and PCNA in mouse ear fibroblasts (Fig. 3b, c) . This co-expression also suppressed the levels of fragile telomeres ( Fig. 3d ), rescued the DNA replication defects ( Fig. 3e , f, Extended Data Fig. 7a, b) , and suppressed the formation of micronuclei, mitotic catastrophe and 53BP1 foci in mouse ear fibroblasts expressing the phospho-dead Flag-TRF2(S367A) mutant (Extended Data Fig. 7c-f ). These data suggest that the TRF2(S367A) mutant sequesters the endogenous pool of RTEL1, potentially at both telomeres and pericentromeric regions 12 , which restricts its ability to engage with PCNA leading to replication stress at telomeres and across the genome.
RTEL1 has been shown to unwind D-loops based on genetic studies and its ability to resolve such structures in vitro 13 . However, evidence demonstrating a direct role in unwinding t-loops in vivo, which contain a D-loop at the point of strand invasion, remains lacking. Because the TRF2(S367A) phospho-dead mutant sequesters RTEL1 at telomeres, we asked what would happen to t-loops in this context. Visualization of telomere secondary structures by Airyscan super-resolution microscopy revealed no measurable reduction in t-loop abundance in TRF2-null cells expressing wild-type TRF2 13 (Fig. 4a , Extended Data Fig. 8a ). However, the frequency of t-loops was significantly diminished in TRF2-null cells expressing the Myc-TRF(S367A) phospho-dead mutant (Fig. 4b, c ). Hence, sequestration of RTEL1 at telomeres leads to promiscuous t-loop unwinding, decreasing the overall levels of t-loops.
The spurious t-loop unwinding observed in the TRF2(S367A) mutant presented an opportunity to directly test whether t-loops are important for suppressing the DNA damage response (DDR) at telomeres. Analysis of TRF2-null cells expressing the phospho-dead Myc-TRF2(S367A) mutant revealed a largely ATM-dependent DDR induction at telomeres, albeit with a modest accumulation of DNA damage-induced RPA foci and activation of ATR due to telomere fragility ( Fig. 4d -g, Extended Data Fig. 8b-d ). Measuring the lengths of telomere contours in super-resolution micrographs revealed that linear telomeres from cells expressing Myc-TRF2(S367A) overlapped in length distribution with looped telomeres from the wild-type Myc-TRF2 control with protected chromosome ends (Extended Data Fig. 8e , f). These data suggest that promiscuous t-loop unwinding results in linear telomeres that activate an ATM-dependent DDR (Fig. 1c ). Collectively, these data reveal that the t-loop structure is important for suppressing the activation of ATM at telomere ends.
In conclusion, our study identifies a phospho-switch in TRF2 that regulates the transient recruitment and release of RTEL1 from telomeres, which is required to temporarily disassemble t-loops during S phase to avert telomere catastrophe 7, 8, 14 , while also preventing promiscuous t-loop unwinding during other cell cycle stages. We suggest that such exquisite control of TRF2 to regulate t-loop opening and the need to 'protect' t-loops from promiscuous unwinding by RTEL1 outside of S phase, further demonstrate that t-loops are essential for physiological telomere homeostasis and chromosome end protection.
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Methods
Cell culture procedures SV40-LT-immortalized Rtel1 F/F MEFs 7 , Trf2 F/− MEFs (a gift from T. de Lange) 3 , Trf2 F/F ;Rosa26 CreERT2 MEFs a gift from E. Lazzerini-Denchi) 15 and Trf2 F/F ;Rtel1 F/F mouse ear fibroblasts were cultured in DMEM supplemented with 15% fetal bovine serum (FBS; Invitrogen), l-glutamine and penicillin-streptomycin. HEK 293 and Phoenix Ampho 293 cells were kept in DMEM with 10% FBS. Trf2 F/F ;Rtel1 F/F conditional doubleknockout mouse ear fibroblasts were isolated from adult mice obtained by crossing of the individual targeted Trf2 F/F and Rtel1 F/F mice. Genotypes were determined by Transnetyx using quantitative PCR with allelespecific probes. Production of retroviral supernatants and transductions of Rtel1 F/F and Trf2 F/− MEFs were done essentially as previously described 8 . Trf2 F/− MEFs were infected with pLPC-puromycin retroviruses expressing control vector, Myc-tagged wild-type TRF2 or S367 mutants. Trf2 F/F ;Rosa26 CreERT2 MEFs were infected with pLPC-puromycin retroviruses expressing Myc-tagged wild-type TRF2 or mutant TRF2(S367A). Human HEK 293 cells were transduced with pLPC-puromycin retroviruses carrying Myc-tagged wild-type or mutant (S365A) TRF2. Trf2 F/F ;Rtel1 F/F mouse ear fibroblasts were complemented with pLPChygromycin retroviruses carrying Flag-tagged TRF2(S367A) and pBABEpuromycin retroviruses expressing mouse V5-tagged wild-type RTEL1 or RTEL1(R1237H) mutant. Transduced cells were selected with puromycin (2 µg ml −1 ) for 2-6 days. Trf2 F/F ;Rtel1 F/F mouse ear fibroblasts were kept under puromycin (2 µg ml −1 ) and hygromycin (150 µg ml −1 ) selection for 5 days. Deletion of floxed alleles in Rtel1 F/F and Trf2 F/− MEFs was carried out with Ad-Cre-GFP adenovirus (Vector Biolabs) and cells were genotyped by PCR at 96 h after infection as previously described 3, 7 . TRF2 was deleted in Trf2 F/F ;Rosa26 CreERT2 MEFs by adding 1 µM 4-hydroxytamoxifen (Sigma-Aldrich) to the culture medium. Cell lines were routinely tested for mycoplasma contamination with negative results.
Cell lysis, western blotting, immunoprecipitation and drug treatments
Cells were rinsed twice with PBS, transferred to an ice-cold NET lysis buffer (50 mM Tris (pH 7.2), 150 mM NaCl, 0.5% NP-40, 1× EDTA-free Complete protease inhibitor cocktail (Roche), 1× PhosSTOP phosphatase inhibitor cocktail (Roche)) and lysed for 10 min on ice. The cell lysates were then briefly vortexed and passed through a 23G syringe five times. The soluble protein fractions were collected after centrifugation at 16,000g for 10 min at 4 °C. Western blotting analysis was performed as previously described 7 . Immunoblots of whole-cell extracts from Trf2 F/F ;Rosa26 CreERT2 cells with or without exogenous expression of the Myc-TRF2 allele was performed as previously described 13 . For protein immunoprecipitation, whole-cell extracts were precleared with protein G Sepharose (Sigma-Aldrich) and 1-2 mg of precleared extract was incubated with the indicated antibodies. Immunocomplexes were subjected to SDS-PAGE followed by immunoblotting using nitrocellulose membrane (GE Healthcare). See Supplementary Table 1 for a list of antibodies used. For inhibition of CDKs, R-roscovitine (Sigma-Aldrich), was used at a final concentration of 10 µM for 24 h. PLK-1 was inhibited by BI-2536 (Axon Medchem) at a final concentration of 100 nM for 24 h. The MEK-ERK signalling pathway was inhibited by the MEK1 and MEK2 inhibitor U0126 (Selleckchem), at a concentration of 30 µM for 24 h. An equal amount of DMSO was used as a vehicle control.
siRNA treatment and siRNA oligonucleotides
Transfections with siRNA oligonucleotides were performed using the Lipofectamin RNAiMax (Thermo Fisher Scientific). In brief, human cells at density of 2.0 × 10 5 cells per well were transfected in a 6-well plate with 40 pmol siRNA. Mouse cells at density of 3.0 × 10 5 cells per well were transfected with 150 pmol siRNA. The medium was exchanged 24 h after transfection. Then, 72 h after transfection, the cells were collected and the levels of proteins of interest were assessed by immunoblot analyses as described. For silencing experiments in human and mouse cells, pre-designed SMARTpool ON-TARGETplus and Accell siRNA oligonucleotides (Dharmacon; GE Healthcare) were used, respectively. For siRNA oligonucleotides details, see Supplementary Table 2 .
λ-Phosphatase treatment
Whole-cell extracts were prepared as described above except in the absence of phosphatase inhibitors. Lysates were incubated with 800 U of λ-phosphatase (New England Biolabs) in NET lysis buffer supplemented with 1 mM of MnCl 2 along with protease inhibitors for 30 min at 30 °C. Next, the lysates were incubated on ice for 15 min and subjected to immunoprecipitation as detailed in the main text.
In vitro kinase assay
Whole-cell extracts from HEK 293 cells were incubated for 1 h at 4 °C with the rabbit polyclonal anti-RTEL1 antibody. Immunocomplexes were coupled to protein G Sepharose beads for an additional 1 h at 4 °C and washed three times with the NET lysis buffer followed by two washes with kinase buffer (20 mM Tris, pH 7.5, 50 mM KCl, 7.5 mM MgCl 2 , 10 mM MnCl 2 , 1 mM DTT, 1× PhosSTOP phosphatase inhibitors). Kinase reactions were performed by incubating the immunocomplexes with 20 µl of kinase buffer containing cold adenosine triphosphate (ATP) and 1 µg recombinant CDK2-cyclinA protein complex for 20 min at 37 °C. Reactions were washed twice with kinase buffer and terminated by the addition of 5× SDS-PAGE sample buffer, and resolved by SDS-PAGE.
Generation of pTRF2(Ser365/367) phospho-specific antibodies
Rabbit polyclonal antibodies against human TRF2 phosphorylated at Ser365 and mouse TRF2 phosphorylated at Ser367 were generated by Kaneka Eurogentec S.A. Biologics Division. The antibodies were raised against the phosphorylated human C-(PTQALPA[pS]PALKNKR)-N and mouse C-(ANLASPS[pS]PAHKHKR)-N TRF2 sequences conjugated through the added C-terminal cysteine to keyhole limpet hemocyanin (KLH). Phosphoserine 365-and 367-specific antibodies were purified with the use of the corresponding sulfolinked phospho-and unphosphorylated peptides. The specificity of each antibody was confirmed by ELISA and immunoblot assays.
Peptide synthesis and peptide pull-down experiments
The peptide pull-down was carried out using the biotinylated peptides. In brief, 36 µg of each of the peptides was coupled to 40 µl of streptavidin-coated magnetic beads (Invitrogen) and added to 1 mg of nuclear extract of HEK 293 cells expressing pHAGE-HA-Flag-RTEL1. Nuclear extracts were precleared by incubation for 30 min at room temperature with uncoupled beads before pull-down incubation. The coupled beads and the lysates were incubated for 2 h at 4 °C. The beads were washed four times with TBST (Tris-buffered saline, 0.1% Tween-20), resuspended in 2× SDS loading sample buffer, and boiled for 5 min.
Slot-blot assay TRF2 peptides diluted into a final volume of 200 µl in SSC 2×
were applied under gentle vacuum to Trans-Blot nitrocellulose membrane (Bio-Rad) using a Minifold 48 slots, Whatman apparatus (GE Healthcare). Each well was washed with 200 µl aliquots of SSC 2×. After removing SSC 2× with gentle suction, the membrane was removed from the apparatus and washed once with SSC 2×. The membrane was blocked at room temperature in a blocking buffer (5% BSA in TBST) for 1 h and probed with horseradish peroxidase (HRP)-conjugated anti-biotin antibody. Incubation was allowed to proceed for 1 h at 4 °C with rocking. After incubation, the antibody solution was removed and the membrane rinsed twice with TBST followed by detection by the ECL method.
Site-directed mutagenesis
Amino acid substitutions were performed with the primers as indicated in key resources table. Primers were designed with the QuikChange Primer Design Software (Agilent Technologies). Single mutants were generated using the QuikChange Lightning Site-Directed Mutagenesis kit (Agilent Technologies) and double mutants were created with the QuikChange Lightning Multi Site-Directed Mutagenesis kit (Agilent Technologies) according to the manufacturer's instructions. The generated mutants were verified by sequencing to screen against spurious secondary mutations. For primer sequences, see Supplementary Table 2 .
In situ PLA Cells were plated on coverslips at density 5 × 10 4 in 24-well plates and left in culture conditions overnight. The next day, cells were pre-extracted in CSK buffer (10 mM PIPES, pH 6.8, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl 2 , 1 mM EGTA and 0.5% Triton X-100) fixed with 4% formaldehyde in the CSK buffer for 10 min, permeabilized with PBS containing 0.5% (v/v) NP-40 for 5 min, and blocked 30 min with goat serum (5%) in PBS. PLA was performed following the manufacturer's instructions using the Duolink anti-Mouse MINUS and anti-Rabbit PLUS In Situ PLA probes and the Duolink In Situ Detection Reagents Red (Olink Bioscience). Images were acquired with a Zeiss Axio Imager M1 microscope equipped with an ORCA-ER camera (Hamamatsu) and using the Volocity 6.3 software (Perkin Elmer).
Cell cycle synchronization
HEK 293 cells were synchronized by the double-thymidine-block method with minor modifications. In brief, cells were treated with 2 mM thymidine (Sigma-Aldrich) for 18 h, thymidine-free medium for 9 h to release the cells, and 2 mM thymidine was added to medium for an additional 16 h to arrest the cells at the G1-to-S transition. Cells were washed twice with PBS and then released in fresh complete DMEM. Cells were analysed at 70-min time intervals by immunoblotting and in situ PLA assay. For synchronization in mitosis, a thymidine-nocodazole block was used. In brief, cells at a confluence of 60% were treated with 2 mM thymidine for 24 h, washed twice in PBS, and released into complete DMEM for 3 h. Next, cells were treated with 50 µg ml −1 of nocodazole (Sigma-Aldrich) for 15 h, and the cells were washed twice with PBS and a fresh complete medium was added to the cell culture. Synchronized cells were analysed at 90-min time intervals by western blotting with antibodies as indicated.
Indirect immunofluorescence
Cells were washed with PBS and fixed with 4% formaldehyde for 10 min at room temperature, permeabilized with 0.3% Triton Χ-100 in PBS for 5 min at room temperature and then blocked with 3% BSA, 10% FBS in PBS for 1 h at room temperature. Samples were then incubated with rabbit anti-53BP1 antibody overnight at 4 °C, washed with 0.05% Tween-20 in PBS and incubated with anti-rabbit IgG AlexaFluor 594 (Molecular Probes). DNA was counterstained with DAPI and images were acquired using a Zeiss AxioImager M1, using a Hamamatsu digital camera and the Volocity 4.3.2 software (Perkin Elmer).
Airyscan super-resolution imaging
Sample preparation for super-resolution microscopy, cross-linking efficiency determination and Airyscan imaging were performed as described previously 13 .
Super-resolution microscopy scoring criteria
Images obtained from super-resolution microscopy were scored as previously described 1, 13 . Specifically, after capture and processing, images were exported to ImageJ as .tif images with maintained scales. Images were manually quantified with researchers blinded to the experimental conditions. Telomere molecules were scored if they had a traceable telomere contour of ≥1 µm, and contained no gaps in telomere staining ≥500 nm. Molecules were classified as t-loops when we could discern an individual molecule consisting of a closed loop structure with a single attached tail. Molecules were classified as linear when we observed an individual molecule with two visible ends, containing no loops or branched structures.
All molecules that did not conform to the looped or linear definition were classified as ambiguous. Densely packed areas of coverslips with overlapping telomere molecules were not scored. Each loop and linear molecule were measured for contour length using the ImageJ trace function.
PNA FISH and inmmuofluorescence FISH
Telomeric PNA FISH on cytogenetic chromosome spreads was performed as previously described 7 . In brief, cells were treated with 0.2 µg ml −1 of colcemid for 90 min to arrest cells in metaphase. Trypsinized cells were incubated in 75 mM KCl, fixed with methanol:acetic acid (3:1), and spread on a glass slide. To preserve the chromosome architecture better, the slides were rehydrated in PBS for 5 min, fixed in 4% formaldehyde for 5 min, treated with 1 mg ml −1 pepsin for 10 min at 37 °C, and fixed in 4% formaldehyde for 5 min. Next, slides were dehydrated in 70%, 85% and 100% (v/v) ethanol for 15 min each and air-dried. Metaphase chromosome spreads were hybridized with telomeric TAMRA-TelG 5′-(TTAGGG) 3 -3′ PNA probe (Panagene) and slides were mounted using ProLong Gold antifade with DAPI (Life Technologies). Chromosome images and telomere signals were captured using Zeiss Axio Imager M1 microscope equipped with an ORCA-ER camera (Hamamatsu) controlled by Volocity 6.3 software (Improvision). For interphase immunofluorescence FISH (TIFs), cells grown on #1.5 glass coverslips were fixed for 20 min in 2% (w/v) formaldehyde (Thermo Scientific) at room temperature and immunofluorescence FISH was performed as previously described 7 , using primary 53BP1 antibody (see Supplementary Table 1 ), anti-mouse Alexa Fluor secondary antibody (Molecular Probes) and a TAMRA-TelG 5′-(TTAGGG) 3 -3′ PNA probe (Panagene). Metaphase TIF assays were done as previously described 16 .
In brief, cells were treated with 20 ng ml −1 colcemid for 1 h before collecting and resuspending in a hypotonic buffer of 0.2% trisodium citrate in 0.2% KCl. The cells were swollen for 5 min then cytocentrifuged onto glass slides using a Tharmac Cellspin 1, before fixation and processed for immunolabelling with an anti-γ-H2AX primary antibody and subsequently with anti-mouse Alexa Fluor 568 secondary antibody (Molecular Probes). After a second fixation, the samples were hybridized with an Alexa Fluor 488 conjugated C-rich telomere PNA probe (Panagene), stained with DAPI and mounted with ProLong Gold (Molecular Probes). Automated metaphase finding and image capture was done as previously described 17 using a MetaSystems imaging platform coupled with a ZEISS AxioImager Z.2 microscope using a 63×, 1.4 NA oil objective and appropriate filter cubes, and a CoolCube1 camera (MetaSystems). After acquisition, images were imported into ImageJ (NIH) and Adobe Photoshop CS5 for manual quantification and processing.
Telomere circle assay
Cells grown at a confluence between 70% and 80% were collected from two 10-cm dishes and extraction of genomic DNA for T-circle assay was performed as previously described 7 . Total gDNA was digested by AluI/ HinfI restriction enzymes and the TCA assay was performed with two essential modifications as described 7 : (1) Phi29 DNA (Thermo Scientific) polymerization used a mammalian telomere primer; and (2) Southern blotting membrane was hybridized to a γ 32 P-labelled (TTAGGG) 4 telomeric probe. Southern blot images were captured with Storm 840 scanner and the extent of [ 32 P] incorporation was quantified from the autoradiographs by ImageQuant TL Software Analyzer (Amersham Biosciences). The level of γ[ 32 P] incorporation obtained from the Phi29negative control samples represented the background level, which was subtracted from the values obtained from the samples that contained the Phi29 DNA polymerase.
DNA combing
Cells were sequentially pulse-labelled with 25 µM CldU (Sigma) and 250 µM IdU (Sigma) for 20 min and, after collection of the cells, lowmelting agarose (Sigma) plugs each containing 200,000 cells were prepared. DNA fibres were extracted from the plugs and combed on silanized coverslips using the FiberPrep DNA extraction kit and the molecular combing system (Genomic Vision), according to the manufacturer's instructions. Combed fibres were fixed at 60 °C for 2 h and DNA was denaturated in 0.5 M NaOH for 25 min. Fibres were then blocked in 1% BSA in 0.1% Tween-20 in PBS for 1 h, incubated with rat anti-BrdU (detects CldU, BU1/75, AbD Serotec, 1:200) and mouse anti-BrdU (detects IdU, B44, BD Biosciences, 1:200) for 1 h followed by anti-rat IgG AlexaFluor 594 and anti-mouse IgG AlexaFluor 488 (Molecular Probes, 1:500) for 1.5 h. For DNA combing with single-stranded DNA (ssDNA) staining, cells were sequentially pulse-labelled with 25 µM CldU (Sigma) and 250 µM IdU (Sigma) for 15 min, and, after collection of the cells, low-melting agarose (Sigma) plugs each containing 250,000 cells were prepared. DNA fibres were extracted from the plugs and combed on silanized coverslips using the FiberPrep DNA extraction kit and the molecular combing system (Genomic Vision), according to the manufacturer's instructions. Combed fibres were fixed at 60 °C for 2 h and DNA was denaturated in 0.5 M NaOH for 25 min. Fibres were then blocked in 1% BSA in 0.1% Tween-20 in PBS for 1 h, incubated with rat anti-BrdU (detects CldU, abcam, ab6326, 1:500) and mouse anti-BrdU (detects IdU, B44, BD Biosciences, 1:250) for 1 h followed by anti-rat IgG Alex-aFluor 594 and anti-mouse IgG AlexaFluor 488 (Molecular Probes, 1:500) for 1.5 h. Fibres were then incubated with mouse anti-ssDNA antibody (Millipore, MAB3034, 1:200) for 45 min followed by antimouse IgG AlexaFluor 647 (Molecular Probes, 1:200) for 45 min.
Images were acquired using a Zeiss AxioImager M1, equipped with Hamamatsu digital camera and the Volocity software (Perkin Elmer). Fibre length was analysed using ImageJ (http://rsbweb.nih.gov/ij/).
Mass spectrometric analyses and protein identification
Coomassie-stained polyacrylamide gel slices were excised from SDS-PAGE gels using a scalpel and processed for mass spectrometry using the Janus liquid handling system (PerkinElmer). In brief, the excised protein gel pieces were placed in individual wells of a 96-well microtitre plate and destained with 50% (v/v) acetonitrile and 50 mM ammonium bicarbonate, reduced with 10 mM DTT, and alkylated with 55 mM iodoacetamide. After alkylation, the samples were digested with trypsin (Promega), overnight at 37 °C. The resulting peptides were extracted in 1% (v/v) formic acid, 2% (v/v) acetonitrile. Digests were subsequently analysed by nano-scale capillary LC-MS/MS. Peptide mixtures were separated on a 50 cm, 75 µm i.d. EasySpray C18 LC-MS column over a 30-min gradient and eluted directly into the LTQ Orbitrap Velos (Thermo Scientific) mass spectrometer. The mass spectrometer was operated in data dependent mode with the top-10 most-intense multiply charged precursor ions fragmented in the linear ion trap using collision-induced dissociation. Raw mass spectrometric data were processed in MaxQuant 18 (v.1.3.0.5) for peptide and protein identification, the database search was performed using the Andromeda search engine against the Homo sapiens canonical sequences downloaded from UniProtKB (release 2012_08).
Statistical analysis
Statistical analyses were performed using GraphPad PRISM version 7.0 software (GraphPad). Statistical significance of data was assessed by two-tailed Student t-test or one-way ANOVA unless noted otherwise. Data represent mean ± s.e.m. or mean ± s.d. as indicated. P > 0.05 was considered not significant. No statistical methods were used to predetermine sample size. The experiments were not randomized, and investigators were not blinded to allocation during experiments and outcome assessment unless stated otherwise. c-e, Quantification of micronuclei (c; 500 nuclei per replicate), mitotic catastrophe (d; 500 nuclei per replicate), and 53BP1 foci frequency (e; 150 nuclei per replicate) in Trf2 F/− MEFs complemented as in a. Data are mean ± s.e.m. of three (c, d) or two (e) independent experiments. f, DNA damage in Trf2 F/− MEFs complemented as in a was estimated by counting the frequency of cells with five or more 53BP1 foci. For each independent experiment (n = 2), a minimum of 150 nuclei of each condition were analysed. All P values were determined by one-way ANOVA.
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